Core Laboratories Inc. (CLB) stock

CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3011% above fair value

$9.01−0.03 (-0.33%)

Close on Nov 12, 2026Market cap $412.87MP/E 26.5Yield 0.44%

Core Laboratories statistics

112 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 3, 2027 (estimated, after the close)
Last ex-dividend date: Aug 10, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $412.87M; $1.32B
Enterprise Value: $510.06M; $2.20B
PE Ratio: 26.50; 11.32
PS Ratio: 0.80; 1.46
PB Ratio: 1.49; 1.35
P/TBV Ratio: 2.50; 1.38
P/FCF Ratio: 39.84; 10.92
P/OCF Ratio: 16.72; 4.94

Enterprise valuationIndustry

EV / Sales: 0.99; 1.95
EV / EBITDA: 9.46; 6.28
EV / EBIT: 13.10; 10.81
EV / FCF: 49.21; 11.77

Share statisticsIndustry

Shares Outstanding: 46M; 106M
Shares Change (YoY): -1.72%; 1.81%
Shares Change (QoQ): -0.17%; 0.00%
Float: 45M; 78M
Shares Held by Insiders: 1.46%; 10.2%
Shares Held by Institutions: 115.0%; 68.9%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: 0.76%; 0.16%
Short % of Float: 11.0%; 6.75%
Short % of Shares Outstanding: 10.8%; 5.40%
Days to Cover: 6.76; 4.31

Stock price statisticsIndustry

52-Week High: $20.36; –
52-Week Low: $8.61; –
20-Day Moving Average: $9.76; –
50-Day Moving Average: $10.45; –
200-Day Moving Average: $13.41; –
Average True Range (14): $0.44; –
Price Change (1 Week): 0.90%; 4.63%
Price Change (1 Month): -7.78%; -7.12%
Price Change (3 Months): -27.6%; -6.42%
Price Change (6 Months): -33.1%; -12.7%
Price Change (YTD): -43.8%; 16.1%
Price Change (1 Year): -44.2%; 9.22%
Price Change (3 Years): -52.3%; -5.72%
Price Change (5 Years): -65.5%; 22.5%
Price Change (10 Years): -91.3%; 5.09%
Average Volume (10 Days): 613,503; –
Average Volume (20 Days): 666,045; –
Average Volume (90 Days): 638,634; –
Relative Volume: 0.82; 0.87
Relative Strength Index (14): 35.8; 43.4
Volatility (1 Year): 46.4%; 47.6%
Beta (5 Years): 1.13; 0.67

MarginsIndustry

Gross Margin: 19.1%; 24.3%
Operating Margin: 7.53%; 10.5%
Pretax Margin: 5.38%; 3.70%
Profit Margin: 3.01%; 1.57%
EBITDA Margin: 10.4%; 22.3%
FCF Margin: 2.01%; 3.38%

Returns on capitalIndustry

Return on Equity (ROE): 5.66%; 2.43%
Return on Assets (ROA): 2.64%; 0.12%
Return on Invested Capital (ROIC): 6.01%; 5.17%
Return on Capital Employed (ROCE): 7.93%; 5.57%

Financial positionIndustry

Current Ratio: 2.19; 1.07
Quick Ratio: 1.33; 0.61
Debt / Equity: 0.40; 0.40
Debt / EBITDA: 2.09; 1.73
Debt / FCF: 10.85; 2.45
Net Debt / EBITDA: 1.69; 1.15
Interest Coverage: 3.50; 2.11

GrowthIndustry

Revenue Growth (YoY): -0.15%; 7.22%
Net Income Growth (YoY): -51.6%; 6.67%
EPS Growth (YoY): -50.0%; -13.6%
FCF Growth (YoY): -72.9%; -3.87%
Revenue Growth (3Y CAGR): 2.44%; -0.28%
EPS Growth (3Y CAGR): 14.5%; -18.5%

EfficiencyIndustry

Asset Turnover: 0.88; 0.39
Inventory Turnover: 7.03; 11.27
Revenue Per Employee: $156.59K; $1.65M
Profits Per Employee: $4.71K; $1.81K
Employee Count: 3,300; 326
WACC: 9.67%; 7.79%

Income statement (TTM)Industry

Revenue: $516.74M; $910.96M
Gross Profit: $98.69M; $347.77M
Operating Income: $38.94M; $38.94M
Pretax Income: $27.80M; $16.37M
Net Income: $15.56M; $659.32K
EBITDA: $53.92M; $124.84M
EPS (Diluted): $0.34; $0.19

Balance sheetIndustry

Cash & Short-Term Investments: $21.38M; $30.49M
Total Debt: $112.45M; $1.07B
Net Cash (Debt): -$91.07M; -$47.77M
Net Cash Per Share: -$1.99; -$0.39
Equity (Book Value): $277.97M; $598.56M
Book Value Per Share: $6.07; $10.10
Tangible Book Value: $165.41M; $567.72M
Working Capital: $122.32M; $1.72M

Cash flow (TTM)Industry

Operating Cash Flow: $24.69M; $195.04M
Capital Expenditures: -$14.33M; -$148.70M
Free Cash Flow: $10.36M; $35.40M
FCF Per Share: $0.23; $0.23

Dividends and yieldsIndustry

Earnings Yield: 3.77%; 1.88%
FCF Yield: 2.51%; 2.71%
Dividend Yield: 0.44%; 2.46%
Buyback Yield: 2.52%; 0.31%
Shareholder Yield: 2.96%; 2.09%
Dividend Per Share: $0.04; $0.60
Dividend Growth (YoY): 0.00%; 0.00%
Years of Dividend Growth: 0; 0
Payout Ratio: 11.9%; 33.1%
FCF Payout Ratio: 17.8%; 32.1%

Taxes and interestIndustry

Interest Expense: $11.13M; $46.86M
Income Tax: $12.17M; $7.64M
Effective Tax Rate: 43.8%; 21.5%

Scores and fair valueIndustry

Graham Number: $6.81; $29.41
Graham Upside: -24.4%; 12.6%
Altman Z-Score: 2.56; 1.53
Piotroski F-Score: 7; 5
Lynch Fair Value: $4.92; –
Lynch Upside: -45.4%; 62.7%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	CLB	S&P 500	Difference	CLB per year	S&P 500 per year
1 month	-10.0%	-2.7%	−7.3 pts
3 months	-27.6%	-1.7%	−25.9 pts
Year to date	-43.7%	+11.9%	−55.6 pts
1 year	-41.5%	+12.0%	−53.5 pts
3 years	-53.1%	+78.2%	−131.3 pts	-22.3%	+21.2%
5 years	-65.1%	+73.2%	−138.4 pts	-19.0%	+11.6%
10 years	-90.4%	+309.6%	−400.1 pts	-20.9%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M CLB shares were sold short on Oct 30, 2026, up 0.8% from the previous report, or 10.97% of the shares available to trade. At recent volumes it would take 6.8 days to buy them back. Over the last 20 sessions, 43.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	4,954,684	+0.8%	733,276	6.8
Oct 15, 2026	4,917,178	+1.0%	675,671	7.3
Sep 30, 2026	4,868,011	+11.1%	714,904	6.8
Sep 15, 2026	4,382,706	+7.0%	427,968	10.2
Aug 31, 2026	4,095,677	-3.8%	427,005	9.6
Aug 14, 2026	4,255,516	+1.5%	587,406	7.2
Jul 31, 2026	4,194,215	+4.2%	835,012	5.0
Jul 15, 2026	4,023,689	-32.6%	1,615,519	2.5
Jun 30, 2026	5,971,336	+7.9%	1,032,322	5.8
Jun 15, 2026	5,536,608	-3.0%	577,948	9.6
May 29, 2026	5,710,295	+12.7%	509,181	11.2
May 15, 2026	5,066,718	+2.6%	551,798	9.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in Core Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jul 9, 2010
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CLB.

Compare: CLB vs NINE · CLB vs XPRO · CLB vs KLXE · CLB vs NESR · CLB vs RNGR

Revenue growth-0.1% · median 1.4%

Gross margin19.1% · median 19.4%

Operating margin7.5% · median 3.3%

Net margin3.0% · median 1.3%

Company	Revenue	Growth
NESR	$1.83B	+44.0%
XPRO	$1.55B	-7.1%
KLXE	$654.50M	+1.4%
RNGR	$640.60M	+16.9%
NINE	$561.91M	+1.4%
CLB	$516.74M	-0.1%

Company

Next earnings (est.): Feb 3, 2027, after close
Exchange: NYSE
Industry: Oil & Gas Field Services, NEC
Fiscal year ends: December 31
Employees: 3,300
Held by institutions: 100.0%
Auditor: KPMG LLP
SEC CIK: 1958086

Advertisement
300 × 250

See a number that looks wrong?